Titian Steiger

Molecule AG is a collaborative platform that connects stakeholders in drug development to accelerate the process of bringing novel therapeutics to patients. Molecule AG is based in Neuhausen am Rheinfall, Switzerland and was founded by Paul Kohlhaas, Tyler Golato, and Titian Steiger, with Paul Kohlhaas serving as the CEO since incorporation. The Swiss company turns intellectual property and its development into a liquid and easily investable asset, connecting leading researchers to investment opportunities.

Molecule AG is a collaborative platform that connects stakeholders in drug development to accelerate the process of bringing novel therapeutics to patients. Molecule AG is based in Neuhausen am Rheinfall, Switzerland and was founded by Paul Kohlhaas, Tyler Golato, and Titian Steiger, with Paul Kohlhaas serving as the CEO since incorporation. The Swiss company turns intellectual property and its development into a liquid and easily investable asset, connecting leading researchers to investment opportunities.

Molecule AG is a collaborative platform that connects stakeholders in drug development to accelerate the process of bringing novel therapeutics to patients. Molecule AG is based in Neuhausen am Rheinfall, Switzerland and was founded by Paul Kohlhaas, Tyler Golato, and Titian Steiger, with Paul Kohlhaas serving as the CEO since incorporation. The Swiss company turns intellectual property and its development into a liquid and easily investable asset, connecting leading researchers to investment opportunities.

Molecule AG is a collaborative platform that connects stakeholders in drug development to accelerate the process of bringing novel therapeutics to patients. Molecule AG is based in Neuhausen am Rheinfall, Switzerland and was founded by Paul Kohlhaas, Tyler Golato, and Titian Steiger, with Paul Kohlhaas serving as the CEO since incorporation. The Swiss company turns intellectual property and its development into a liquid and easily investable asset, connecting leading researchers to investment opportunities.

Molecule AG is a collaborative platform that connects stakeholders in drug development to accelerate the process of bringing novel therapeutics to patients. Molecule AG is based in Neuhausen am Rheinfall, Switzerland and was founded by Paul Kohlhaas, Tyler Golato, and Titian Steiger, with Paul Kohlhaas serving as the CEO since incorporation. The Swiss company turns intellectual property and its development into a liquid and easily investable asset, connecting leading researchers to investment opportunities.